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Science in the News
Smuggling a CRISPR gene editor into staph bacteria can kill the pathogen
Lots of bacteria have some antibiotic resistance which gave the difficulty in
treating patients when they have a disease. CRISPR original was discovered in the
bacteria, but now this protein might hold the key to fighting antibiotic resistant bacteria.
CRISPR has become popular in the science field as a new tool for genetic engineering.
Excitingly CRISPR has been applied some cancer gene and also to decrease the ability of
drug-resistant Staphylococcus strains. CRISPR treated cells could change back to the
normal gene or a lose-of-function bacteria. CRISPR was the technology that corrected the
mutated sequence by Cas9 protein. Therefore, there were two different methods to lessen
the infection from staph bacteria. First, the Cas9 protein could cut the staph DNA, and
kill the bacteria. Second, Cas9 targets genes and controlled that lower the danger staph
bacteria to infect human cells.
Moreover, researchers tested the DNA-loaded parcels which injected in the mice
called drones. These parcels would stop the animals from developing an infection
because the mice received the bacteria-killing version survived the injection of S aureus
in their body. This kind of treatment was like phage therapy where depending on which
the kind of infecting bacteria, different mixture of bacteriophages could be used to, target
the bacteria. However, this approach has not been approved for use in the USA. The

drone approach technology was simple, the only thing needed is to express the gene
which killed the bacteria. Even this method effectively targeted Staphylococcus bacteria,
but there were some issues also. There were bacteria strains that did not react to either
method of the treatment in the mouse experiments. For use in the clinical field the
research, still has a long way to go. Therefore, for the next step, the research test other
kind of staph bacteria, like as pneumonia. Moreover, the researchers still need to ensure
that the treatment only works in specific bacteria and there are no off target effects. All-in
all though the research looks like promising approach to treat antibiotic resistance.
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